Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Hardness Testing of Chewable Tablets – V 2.0

Posted on By

Tablets: SOP for Hardness Testing of Chewable Tablets – V 2.0

Standard Operating Procedure for Hardness Testing of Chewable Tablets

Department Tablet
SOP No. SOP/TAB/078/2025
Supersedes SOP/TAB/078/2022
Page No. Page 1 of 6
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

To define the procedure for conducting hardness testing of chewable tablets to ensure that the tablets meet the required mechanical strength and are capable of withstanding physical stress during handling and packaging.

2. Scope

This SOP applies to the hardness testing of chewable tablets, ensuring that they possess the necessary hardness to withstand the conditions of transportation, storage, and use while remaining easy to chew and digest.

3. Responsibilities

  • Manufacturing Personnel: Responsible for providing chewable tablet samples for hardness testing and ensuring that the tablets are free from visible defects.
  • Quality Control (QC): Responsible for performing the hardness test, recording the results, and ensuring that the tablets meet the specified hardness criteria.
  • Quality Assurance (QA): Ensures that the testing procedure is followed correctly and reviews the results for final batch approval and release.

4. Accountability

The QC Manager is accountable for ensuring that the hardness test is conducted in compliance with this SOP and for reporting the results.

The QA Manager is responsible for reviewing the results and approving the batch for release.

See also  Tablets: SOP for Osmolarity Testing for Chewable and Dispersible Tablets - V 2.0

5. Procedure

5.1 Sample Collection

  1. Collect a representative sample of chewable tablets from the batch as specified in the batch record.
  2. The sample should consist of 10 tablets (or as specified in the batch record or pharmacopeial guidelines).
  3. Ensure that the tablets are free from any defects such as cracks, chips, or visible contamination.
  4. Label the sample appropriately for identification during testing.

5.2 Preparation of Hardness Testing Apparatus

  1. Ensure that the hardness testing apparatus is clean, calibrated, and functioning properly according to the manufacturer’s instructions.
  2. Set the testing apparatus to the appropriate test settings, ensuring it is ready to measure tablet hardness according to the guidelines.
  3. Verify that the apparatus has been checked for accuracy and is in good condition before use.

5.3 Performing Hardness Test

  1. Place each tablet on the hardness tester and apply the required pressure to measure the force needed to break the tablet.
  2. Record the force in kilograms (kg) or Newtons (N), as required by the testing method.
  3. Repeat the test for each tablet in the sample (typically 10 tablets per sample).

5.4 Data Recording and Calculation

  1. Record the hardness values for each tablet in the batch record (Annexure-1).
  2. Calculate the average hardness value for the sample, as well as the standard deviation to assess uniformity.
  3. Ensure that the average hardness falls within the specified range, typically 4–8 kg for chewable tablets, but this may vary depending on the product specifications.
See also  Tablets: SOP for Risk Assessment in Tablet Manufacturing Processes - V 2.0

5.5 Hardness Acceptance Criteria

  1. Ensure that the hardness of the tablets falls within the established limits, as defined in the batch record or pharmacopeial guidelines.
  2. If any tablet fails to meet the hardness criteria, document the findings in the batch record and initiate an investigation to determine the cause of the failure (Annexure-2).

5.6 Documentation and Record-Keeping

  1. Document all hardness testing results, including the individual tablet hardness values and the average hardness, in the batch record (Annexure-1).
  2. Record any deviations from the established hardness specifications in the deviation report (Annexure-2), along with the corrective actions taken.
  3. Ensure all records are signed, dated, and stored according to the company’s record retention policy for future audits and inspections.

5.7 Post-Test Cleanup

  1. Clean the hardness tester and any associated equipment after each test according to the manufacturer’s instructions and the company’s cleaning SOP.
  2. Ensure that all testing equipment is properly stored and maintained in good working condition.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • API: Active Pharmaceutical Ingredient
See also  Tablets: SOP for Robustness Testing of Analytical Methods for Tablets - V 2.0

7. Documents

  1. Batch Record (Annexure-1)
  2. Deviation Report (Annexure-2)

8. References

  • USP <1217> – Tablet Hardness Test
  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • European Pharmacopoeia (EP) – Testing for Tablet Hardness

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Batch Record

Batch Number Tablet Sample Hardness (kg) Average Hardness (kg)
Batch 001 10 tablets 5.0 5.2

Annexure-2: Deviation Report

Deviation Date Batch Number Deviation Description Corrective Action Responsible Person
10/12/2025 Batch 001 Tablet hardness below specification Adjusted formulation for hardness John Doe

You said:
Continue
ChatGPT said:
Here is the continuation of the SOP for “Hardness Testing of Chewable Tablets” in HTML format:

html
Copy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated Test Parameters Refined hardness testing procedure QA Head
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: SOP for Screening Hydrogels for Drug Delivery Applications
Next Post: Ointments: SOP for Conducting On-the-Spot Microbial Testing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version